Title : Dopamine release in prefrontal cortex in response to beta-amyloid activation of alpha7 * nicotinic receptors.

Pub. Date : 2007 Nov 28

PMID : 17935702






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The Abeta(1-42)-evoked dopamine release was sensitive to antagonists of alpha7 nicotinic receptors and was absent in mice harboring a null mutation for the alpha7 nicotinic subunit, but was intact in mice harboring a null mutation for the beta2 nicotinic subunit. Dopamine histocompatibility 2, class II antigen A, beta 1 Mus musculus
2 In the present study, soluble Abeta was perfused into mouse prefrontal cortex and the effect on the release of dopamine outflow via microdialysis was assessed. Dopamine histocompatibility 2, class II antigen A, beta 1 Mus musculus
3 In the presence of tetrodotoxin, Abeta(1-42) at 100 nM evoked the release of dopamine to approximately 170% of basal levels. Tetrodotoxin histocompatibility 2, class II antigen A, beta 1 Mus musculus
4 In the presence of tetrodotoxin, Abeta(1-42) at 100 nM evoked the release of dopamine to approximately 170% of basal levels. Dopamine histocompatibility 2, class II antigen A, beta 1 Mus musculus
5 In contrast, Abeta(1-42) at 1-10 pM caused a profound but slowly developing decrease in dopamine outflow. Dopamine histocompatibility 2, class II antigen A, beta 1 Mus musculus
6 These results suggest that Abeta alters dopamine release in mouse prefrontal cortex, perhaps involving distinct targets as it accumulates during Alzheimer"s disease and leading to disruption of synaptic signaling. Dopamine histocompatibility 2, class II antigen A, beta 1 Mus musculus